Nektar Therapeutics (NASDAQ: NKTR), a biopharmaceutical Company engaged in developing candidates for oncology, auto-immune and chronic pain, has announced the withdrawal of its application for oxycodegol (formerly NKTR-181), as it received adverse advisory committee decision from both Anesthetic and Analgesic Drug Products Advisory Committee, and...
Systemic lupus erythematosus (SLE) is an autoimmune disease that causes the body’s immune system to attack healthy tissue causing inflammation, photosensitivity, oral ulcers, pleuritis, joint pain, arthritis, fever and a butterfly rash. In the long-run it can affect the kidneys, brain and heart as well....
For anyone having a stroke, time is everything. Getting help quickly can make a difference between recovery and disability. Read more: https://www.aviseanalytics.com/5-promising-stocks-in-the-stroke-management-industry/ Visit: www.aviseanalytics.com...
An increase in the geriatric population, coupled with a rise in lifestyle diseases such as hypertension, diabetes and coronary cardiac diseases are driving the growth in the stroke diagnostics and therapeutics market not only in the US but in Europe and Asia as well. The market...
